While assigned to the Home Office on the Advisory Council on the Misuse of Drugs (ACMD) during my tenure on the Science and Engineering Faststream. The ACMD was dealing with a constitutional crisis concerning quorum maintenance which was critical for potential amendments to the Misuse of Drugs Act 1971. Additionally, I was tasked with providing key advice to the government on the regulations concerning commercial CBD products and the research barriers caused by regulations on Synthetic Cannabinoid Receptor Agonists (SCRA).

To address the constitutional crisis, I worked with Prof Owen Bowden-Jones (the chair of the ACMD) to draft a proposal to the Home Secretary and Prime Minister, suggesting a strategy for maintaining quorum and continuing operations. Regarding SCRA regulations, I worked with Professor Roger Knaggs to suggest a revised definition for research organizations, advocating for more lenient regulations to aid UK research. Professor Graeme Henderson and myself also recommended changes to the exempt product definition to allow legal sale of CBD products. We further proposed limitations on psychoactive substance impurities within CBD, guided by the latest knowledge on their side effects.

My advice helped the ACMD remain quorate, successfully hiring and retaining the required number of members. As a result of the advice on SCRA regulations, the government commissioned additional work to consider these in the context of all other Schedule 1 compounds. The recommendations on CBD are still under consideration by the government.